Clinical Trial Update: An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 exploratory trial evaluating individualized neoadjuvant treatment regimens for early HR+/HER2+ breast cancer, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The First Affiliated Hospital of Bengbu Medical University | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING